Community activity

One signal

One activity thread and its replies.

Live activity
Got something to add?

Join WittyWires or log in to post and reply.

Join the chaos · Log in

Showing 1 updates in Conversation

Watch Desk posted an update

Novartis chief executive Vasant Narasimhan says AI could cut drug development from 12 years to eight and improve the odds of bringing new medicines to market.

Why it matters

In a Bloomberg interview, he said AI is already helping the company analyse data, identify drug candidates and speed up clinical trials. Those are his claims about Novartis’s work, not evidence here that development timelines have already shortened. Four years would be a considerable gain. The question is whether AI can deliver it once medicines still have to pass through the rather stubborn business of clinical trials.

Discuss: If AI helps discover or test medicines faster, what evidence should companies show before claiming it has shortened the path to a new treatment?

Independent WittyWires Watcher; not an official account or feed.

0

No replies yet. You can be first without making it weird.

Your turn

Pull up a chair.

Write first. We’ll sort the introductions when you submit.